Browsing Pharmaceutical Sciences by Subject "Angiotensin II--Antagonists."
Now showing items 1-1 of 1
[2011-07-02] Comparison of monotherapy with angiotensin-converting enzyme inhibitors or angtiotensin receptor blockers in improving health outcomes among veteran patients with type 2 diabetes Diabetes is a world-wide epidemic; 90-95% of diabetes cases are type 2 in nature. Albuminuria and hypertension are risk factors of diabetes complications, specifically nephropathy and cardiovascular disease. Angiotensi ...